To reduce the risk of catheter related bloodstream infection
Subscribe to our email newsletter
Ethicon, a Johnson & Johnson company, has revealed that Biopatch Protective Disk with CHG (chlorhexidine gluconate) will include new design elements and updated packaging.
The company said that the product will help surgeons, nurses and other healthcare providers to apply the product correctly around catheters to reduce the risk of catheter-related bloodstream infections (CRBSIs).
The company claims that the new design and packaging for Biopatch includes instructions and clearly marked up arrows to signify correct application with respect to skin orientation of the product. In addition, Biopatch packaging now features color-coded elements designed to instantly identify the size and center-hole diameter of the product.
The company said that the product is placed directly on the skin at the point of catheter insertion and provides seven days of continuous active antisepsis.
According to the company the distribution of Biopatch with the enhanced design and packaging began on August 10, 2009 and the product will be available nationwide by mid-August.
Leigh Ann Bowe-Geddes, a vascular access specialist at the University of Louisville Hospital in Louisville, said: “Proper application of a medical device is essential for maximizing efficacy. The new design of Biopatch helps ensure that this technology is used properly, which helps protect patients in the fight against infection.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.